Sanctuary Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Sanctuary Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,032	Closed	-$102K	–	2468
2025 Q2	$102K	Sell	3,032 -33	-1%	-$1.04K	﹤0.01%	2271
2025 Q1	$97.5K	Buy	3,065 +523	+21%	+$19.8K	﹤0.01%	2116
2024 Q4	$104K	Buy	+2,542	New	+$107K	﹤0.01%	2314
2024 Q3	–	Sell	-15,042	Closed	-$590K	–	2563
2024 Q2	$590K	Buy	+15,042	New	+$629K	﹤0.01%	1535

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Sanctuary Advisors's GNOM Position: Q3 2025 in Review

Sanctuary Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 3,032 shares — an estimated $102K sold.

Sanctuary Advisors first reported a position in GNOM in Q2 2024 and held it in 4 quarters. The position peaked at $590K in Q2 2024. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Sanctuary Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Sanctuary Advisors sold 3,032 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $102K.
Sanctuary Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 4 quarters.
Sanctuary Advisors's Global X Genomics & Biotechnology ETF position peaked at $590K in Q2 2024.
43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Sanctuary Advisors's 13F filing for Q3 2025, filed 6 Jan 2026.